bg
E

Erasca (ERAS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Erasca (ERAS)

Erasca, Inc is a clinical-stage precision oncology company. The Company is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The Company is engaged in oncology and RAS targeting to cr... Read more

  • USD1.60
  • USD1.67
  • USD1.57
  • USD3.45
  • 28.00%
  • --
  • 1.73M
  • 1.65M
  • 397M
  • 1.01
  • -32.10%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.